Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Rentokil buys $425 mln U.S. pest control business Steritech

Published 01/09/2015, 08:47
© Reuters.  Rentokil buys $425 mln U.S. pest control business Steritech

By Li-mei Hoang

LONDON (Reuters) - British support services company Rentokil Initial (L:RTO) has continued its North American expansion with its biggest deal in 10 years, agreeing to buy pest control business Steritech for $425 million.

Rentokil said the deal, which is subject to regulatory approval, strengthens its position as the No.3 pest control business in a U.S. market worth about $7.5 billion.

Revenue from Rentokil's North American operations now account for $800 million, making it the biggest operation in the group, the company added.

"It is going to drive our revenues more aggressively and really give us an opportunity to improve our North American margins significantly," Chief Executive Andy Ransom said of the Steritech deal.

Rentokil, which offers services from pest control to the supply of workwear, has made about 40 acquisitions in the past 18 months, 20 of which were in North America.

The group's shares were up 1.4 percent at 150 pence at 0735 GMT, roughly in line with the mid-cap FTSE (FTMC) index.

"The market is likely to be neutral on the deal until the earnings improvements start to come through, though clearly at such rates the deal is earnings-enhancing from the start," said Stephen Rawlinson, analyst at brokerage Whitman Howard.

"It also begs questions about future disposals at Rentokil, given the clear strategic intention to be a global leader in pest control."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.